Skip to main content

Table 7 Rates of recurrences in the literature

From: Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases

Paper Total number of casesb Cases with known risk factor Recurrence rate in high risk cases Overall recurrence rate (%) Follow up (months)
Wright (1951) [16] 54 a a 44 1–120
Sherry and Anderson (1955) [17] 12 a a 25 12–72
Jones (1969) [18] 72 53 joint involvement a 22 1–120
Fyfe and MacFarlane (1980) [19] 51 30 joint involvement a 38 6–240
Rao and Vigorita (1984) [20] 17 a a 29 3–108
Moore et al. (1984) [21] 115 53 joint involvement, 10 bone involvement a 9 1–324
Grover et al. (1998) [22] 52 7 bone involvement, 13 tumor was Al Qattan type 2 57% with bone involvement; 30% with Al Qattan type 2 15 7–174
Looi et al. (1999) [23] 53 21 bone involvement a 7 12–60
Reilly et al. (1999) [8] 70 10 bone involvement, 30 joint involvement 50% with bone involvement; 42% with joint involvement, 27 7–138
Kotwal et al. (2000) [13] 48 a a 4 24–132
Al-Qattan (2001) [5] 43 13 tumor was Al Qattan type 2 38% with Al Qattan type 2 11 24–72
Ozalp et al. (2004) [24] 134 a a 16 6–132
Kigawa et al. (2004) [12] 30 3 a 13 12–126
Lowyck and De Smet (2006) [25] 43 27 joint involvement, 8 bone involvement 0% with bone involvement; 14% with joint involvement 16 15–136
Darwish (2008) [2] 52 a a 24 36–120
Williams et al. (2010) [10] 213 10 bone involvement, 40 joint involvement, 23 neurovascular involvement 10% with bone involvement; 30% with joint involvement, 22% with neurovascular involvement 13 36-a
Di Grazia et al. (2013) [4] 64 7 neurovascular involvement 42% with neurovascular involvement 4.7 2–153
Koutserimpas et al. (2018) [6] 36 9 tumor was Al Qattan type 2 a 11 a
  1. aNot reported
  2. bNumber of cases included in the study
\